Clinical Case Reports 2020-Apr
Dasatinib-induced hypoglycemia in a patient with acute lymphoblastic leukemia
只有註冊用戶可以翻譯文章
登陸註冊
鏈接已保存到剪貼板
關鍵詞
抽象
Tyrosine kinase inhibitors can cause significant hypoglycemia in patients with diabetes on other antihyperglycemic medications. These patients should be monitored, and their medications adjusted accordingly.
Keywords: acute lymphoblastic leukemia; adverse effect; diabetes; hypoglycemia; tyrosine kinase inhibitor.
